keyword
https://read.qxmd.com/read/38617360/apobec-shapes-tumor-evolution-and-age-at-onset-of-lung-cancer-in-smokers
#41
Tongwu Zhang, Jian Sang, Phuc H Hoang, Wei Zhao, Jennifer Rosenbaum, Kofi Ennu Johnson, Leszek J Klimczak, John McElderry, Alyssa Klein, Christopher Wirth, Erik N Bergstrom, Marcos Díaz-Gay, Raviteja Vangara, Frank Colon-Matos, Amy Hutchinson, Scott M Lawrence, Nathan Cole, Bin Zhu, Teresa M Przytycka, Jianxin Shi, Neil E Caporaso, Robert Homer, Angela C Pesatori, Dario Consonni, Marcin Imielinski, Stephen J Chanock, David C Wedge, Dmitry A Gordenin, Ludmil B Alexandrov, Reuben S Harris, Maria Teresa Landi
APOBEC enzymes are part of the innate immunity and are responsible for restricting viruses and retroelements by deaminating cytosine residues 1,2 . Most solid tumors harbor different levels of somatic mutations attributed to the off-target activities of APOBEC3A (A3A) and/or APOBEC3B (A3B) 3-6 . However, how APOBEC3A/B enzymes shape the tumor evolution in the presence of exogenous mutagenic processes is largely unknown. Here, by combining deep whole-genome sequencing with multi-omics profiling of 309 lung cancers from smokers with detailed tobacco smoking information, we identify two subtypes defined by low ( LAS ) and high ( HAS ) APOBEC mutagenesis...
April 3, 2024: bioRxiv
https://read.qxmd.com/read/38607074/unlocking-the-future-pluripotent-stem-cell-based-lung-repair
#42
REVIEW
Tobias Goecke, Fabio Ius, Arjang Ruhparwar, Ulrich Martin
The human respiratory system is susceptible to a variety of diseases, ranging from chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis to acute respiratory distress syndrome (ARDS). Today, lung diseases represent one of the major challenges to the health care sector and represent one of the leading causes of death worldwide. Current treatment options often focus on managing symptoms rather than addressing the underlying cause of the disease. The limitations of conventional therapies highlight the urgent clinical need for innovative solutions capable of repairing damaged lung tissue at a fundamental level...
April 5, 2024: Cells
https://read.qxmd.com/read/38602915/il-6-gp130-signaling-in-cd4-t-cells-drives-the-pathogenesis-of-pulmonary-hypertension
#43
JOURNAL ARTICLE
Tomohiko Ishibashi, Tadakatsu Inagaki, Makoto Okazawa, Akiko Yamagishi, Keiko Ohta-Ogo, Ryotaro Asano, Takeshi Masaki, Yui Kotani, Xin Ding, Tomomi Chikaishi-Kirino, Noriko Maedera, Manabu Shirai, Kinta Hatakeyama, Yoshiaki Kubota, Tadamitsu Kishimoto, Yoshikazu Nakaoka
Pulmonary arterial hypertension (PAH) is characterized by stenosis and occlusions of small pulmonary arteries, leading to elevated pulmonary arterial pressure and right heart failure. Although accumulating evidence shows the importance of interleukin (IL)-6 in the pathogenesis of PAH, the target cells of IL-6 are poorly understood. Using mice harboring the floxed allele of gp130 , a subunit of the IL-6 receptor, we found substantial Cre recombination in all hematopoietic cell lineages from the primitive hematopoietic stem cell level in SM22α-Cre mice...
April 16, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38598345/pharmacological-expansion-of-type-2-alveolar-epithelial-cells-promotes-regenerative-lower-airway-repair
#44
JOURNAL ARTICLE
Sida Shao, Nan Zhang, Gregory P Specht, Shaochen You, Lirui Song, Qiangwei Fu, David Huang, Hengyao You, Jian Shu, Alain Domissy, Shuangwei Li, Van Nguyen-Tran, Sean B Joseph, Arnab K Chatterjee, Jeffrey Jian Chen, Peter G Schultz, Michael J Bollong
Type 2 alveolar epithelial cells (AEC2s) are stem cells in the adult lung that contribute to lower airway repair. Agents that promote the selective expansion of these cells might stimulate regeneration of the compromised alveolar epithelium, an etiology-defining event in several pulmonary diseases. From a high-content imaging screen of the drug repurposing library ReFRAME, we identified that dipeptidyl peptidase 4 (DPP4) inhibitors, widely used type 2 diabetes medications, selectively expand AEC2s and are broadly efficacious in several mouse models of lung damage...
April 16, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38590657/pirfenidone-ameliorates-alcohol-induced-promotion-of-breast-cancer-in-mice
#45
JOURNAL ARTICLE
Hui Li, Mei Xu, Danlei Chen, Wen Wen, Jia Luo
PURPOSE: Alcohol consumption increases the risk of breast cancer and promotes cancer progression. Alcohol exposure could affect both processes of the mammary carcinogenesis, namely, the cell transformation and onset of tumorigenesis as well as cancer aggressiveness including metastasis and drug resistance/recurrence. However, the cellular and molecular mechanisms underlying alcohol tumor promotion remain unclear. There are four members of the mammalian p38 mitogen-activated protein kinase (MAPK) family, namely, p38α, p38β, p38γ and p38δ...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38585863/impaired-ampk-control-of-alveolar-epithelial-cell-metabolism-promotes-pulmonary-fibrosis
#46
Luis R Rodriguez, Konstantinos-Dionysios Alysandratos, Jeremy Katzen, Aditi Murthy, Willy Roque Barboza, Yaniv Tomer, Rebeca Acin-Perez, Anton Petcherski, Kasey Minakin, Paige Carson, Swati Iyer, Katrina Chavez, Charlotte H Cooper, Apoorva Babu, Aaron I Weiner, Andrew E Vaughan, Zoltan Arany, Orian S Shirihai, Darrell N Kotton, Michael F Beers
Alveolar epithelial type II (AT2) cell dysfunction is implicated in the pathogenesis of familial and sporadic idiopathic pulmonary fibrosis (IPF). We previously described that expression of an AT2 cell exclusive disease-associated protein isoform (SP-CI73T) in murine and patient-specific induced pluripotent stem cell (iPSC)-derived AT2 cells leads to a block in late macroautophagy and promotes time-dependent mitochondrial impairments; however, how a metabolically dysfunctional AT2 cell results in fibrosis remains elusive...
March 28, 2024: bioRxiv
https://read.qxmd.com/read/38583771/genome-wide-analysis-identifies-nuclear-factor-1c-as-a-novel-transcription-factor-and-potential-therapeutic-target-in-small-cell-lung-cancer
#47
JOURNAL ARTICLE
Vivek Shukla, Haitao Wang, Lyuba Varticovski, Songjoon Baek, Ruihong Wang, Xinwei Wu, Frank Echtenkamp, Frank Villa Hernandez, Katherine P Prothro, Sudheer K Gara, Mary R Zhang, Stephanie Shiffka, Razi Raziuddin, Leonard M Neckers, W Marston Linehan, Haobin Chen, Gordon L Hager, David S Schrump
BACKGROUND: Recent insights regarding mechanisms mediating stemness, heterogeneity, and metastatic potential of lung cancers have yet to be fully translated to effective regimens for the treatment of these malignancies. This study sought to identify novel targets for lung cancer therapy. METHODS: Transcriptomes and DNA methylomes of 14 SCLC and 10 NSCLC lines were compared to normal human small airway epithelial cells (SAEC) and induced pluripotent stem cell (iPSC) clones derived from SAEC...
April 5, 2024: Journal of Thoracic Oncology
https://read.qxmd.com/read/38582877/a-placebo-controlled-crossover-trial-to-investigate-the-efficacy-of-tiotropium-bromide-or-placebo-added-to-usual-care-in-stable-symptomatic-post-hematopoietic-stem-cell-transplantation-hsct-bronchiolitis-obliterans-syndrome-bos
#48
RANDOMIZED CONTROLLED TRIAL
Naeemeh Dini, Amin Pastaki Khoshbin, Rasoul Aliannejad, Hooman Bakhshandeh, Katayoun Najafizadeh, Mahshid Mehdizadeh, Shahideh Amini
BACKGROUND: Despite the fundamental progress in hematopoietic stem cell transplant, this treatment is also associated with complications. Graft-versus-host disease is a possible complication of HSCT. Bronchiolitis obliterans syndrome (BOS) is the pulmonary form of this syndrome. Due to the high morbidity and mortality rate of BOS, various studies have been conducted in the field of drug therapy for this syndrome, although no standard treatment has yet been proposed. According to the hypotheses about the similarities between BOS and chronic obstructive pulmonary disease, the idea of using tiotropium bromide as a bronchodilator has been proposed...
April 6, 2024: Trials
https://read.qxmd.com/read/38581619/lung-derived-soluble-factors-support-stemness-plasticity-and-metastatic-behaviour-of-breast-cancer-cells-via-the-fgf2-dach1-axis
#49
JOURNAL ARTICLE
Vasudeva Bhat, Matthew Piaseczny, David Goodale, Urvi Patel, Ashkan Sadri, Alison L Allan
Patients with triple-negative breast cancer (TNBC) have an increased propensity to develop lung metastasis. Our previous studies demonstrated that stem-like ALDHhi CD44+ breast cancer cells interact with lung-derived soluble factors, resulting in enhanced migration and lung metastasis particularly in TNBC models. We have also observed that the presence of a primary TNBC tumor can 'prime' the lung microenvironment in preparation for metastasis. In this study, we hypothesized that soluble lung-derived factors secreted in the presence of a primary TNBC tumor can influence stemness/plasticity of breast cancer cells...
April 6, 2024: Clinical & Experimental Metastasis
https://read.qxmd.com/read/38576851/multipotent-adult-progenitor-cells-prevent-functional-impairment-and-improve-development-in-inflammation-driven-detriment-of-preterm-ovine-lungs
#50
JOURNAL ARTICLE
Sophie M L Neuen, Daan R M G Ophelders, Helene Widowski, Matthias C Hütten, Tim Brokken, Charlotte van Gorp, Peter G J Nikkels, Carmen A H Severens-Rijvers, Mireille M J P E Sthijns, Clemens A van Blitterswijk, Freddy J Troost, Vanessa L S LaPointe, Shahab Jolani, Christof Seiler, J Jane Pillow, Tammo Delhaas, Niki L Reynaert, Tim G A M Wolfs
BACKGROUND: Perinatal inflammation increases the risk for bronchopulmonary dysplasia in preterm neonates, but the underlying pathophysiological mechanisms remain largely unknown. Given their anti-inflammatory and regenerative capacity, multipotent adult progenitor cells (MAPC) are a promising cell-based therapy to prevent and/or treat the negative pulmonary consequences of perinatal inflammation in the preterm neonate. Therefore, the pathophysiology underlying adverse preterm lung outcomes following perinatal inflammation and pulmonary benefits of MAPC treatment at the interface of prenatal inflammatory and postnatal ventilation exposures were elucidated...
December 2024: Regenerative Therapy
https://read.qxmd.com/read/38573476/the-main-mechanisms-of-mesenchymal-stem-cell-based-treatments-against-covid-19
#51
REVIEW
Jinling Li, Shipei He, Hang Yang, Lizeai Zhang, Jie Xiao, Chaoyi Liang, Sijia Liu
BACKGROUND: Coronavirus disease 2019 (COVID-19) has a clinical manifestation of hypoxic respiratory failure and acute respiratory distress syndrome. However, COVID-19 still lacks of effective clinical treatments so far. As a promising potential treatment against COVID-19, stem cell therapy raised recently and had attracted much attention. Here we review the mechanisms of mesenchymal stem cell-based treatments against COVID-19, and provide potential cues for the effective control of COVID-19 in the future...
April 4, 2024: Tissue Engineering and Regenerative Medicine
https://read.qxmd.com/read/38567023/combination-of-metagenomic-next-generation-sequencing-and-conventional-tests-unraveled-pathogen-profiles-in-infected-patients-undergoing-allogeneic-hematopoietic-stem-cell-transplantation-in-jilin-province-of-china
#52
JOURNAL ARTICLE
Hongyan Zou, Sujun Gao, Xiaoliang Liu, Yong Liu, Yunping Xiao, Ao Li, Yanfang Jiang
BACKGROUND: Infection is the main cause of death for patients after allogeneic hematopoietic stem cell transplantation (HSCT). However, pathogen profiles still have not been reported in detail due to their heterogeneity caused by geographic region. OBJECTIVE: To evaluate the performance of metagenomic next-generation sequencing (mNGS) and summarize regional pathogen profiles of infected patients after HSCT. METHODS: From February 2021 to August 2022, 64 patients, admitted to the Department of Hematology of The First Hospital of Jilin University for HSCT and diagnosed as suspected infections, were retrospectively enrolled...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38566174/a-wnt-mimetic-with-broad-spectrum-fzd-specificity-decreases-fibrosis-and-improves-function-in-a-pulmonary-damage-model
#53
JOURNAL ARTICLE
Mehaben Patel, Yorick Post, Natalie Hill, Asmiti Sura, Jay Ye, Trevor Fisher, Nicholas Suen, Mengrui Zhang, Leona Cheng, Ariel Pribluda, Hui Chen, Wen-Chen Yeh, Yang Li, Hélène Baribault, Russell B Fletcher
BACKGROUND: Wnt/β-catenin signaling is critical for lung development and AT2 stem cell maintenance in adults, but excessive pathway activation has been associated with pulmonary fibrosis, both in animal models and human diseases such as idiopathic pulmonary fibrosis (IPF). IPF is a detrimental interstitial lung disease, and although two approved drugs limit functional decline, transplantation is the only treatment that extends survival, highlighting the need for regenerative therapies...
April 2, 2024: Respiratory Research
https://read.qxmd.com/read/38560777/outcomes-of-patients-with-diffuse-systemic-sclerosis-eligible-for-autologous-stem-cell-transplantation-managed-with-conventional-therapy
#54
JOURNAL ARTICLE
Kate Gregory, Dylan Hansen, Ross Penglase, Diane Apostolopoulos, Gene-Siew Ngian, Wendy Stevens, Kathleen Morrisroe, Nava Ferdowsi, Laura Ross, Jennifer Walker, Helen Cooley, Peter Youssef, Kathleen Tymms, Lauren Host, Susanna Proudman, John Moore, Mandana Nikpour, Joanne Sahhar
OBJECTIVE: To determine the event-free survival of Australian patients with diffuse systemic sclerosis (dcSSc), who meet eligibility criteria for autologous stem cell transplant (ASCT) in previously published randomised controlled trials (RCTs), but were managed without ASCT. METHODS: Patients who met inclusion criteria for the ASTIS (Autologous Stem Cell Transplantation International Scleroderma)(1) and SCOT (Scleroderma: Cyclophosphamide Or Transplantation)(2) trials were identified from the multicentre Australian Scleroderma Cohort Study (ASCS)...
April 1, 2024: Arthritis & Rheumatology
https://read.qxmd.com/read/38560609/serial-bronchoalveolar-lavage-fluid-aspergillus-galactomannan-and-treatment-response-in-invasive-pulmonary-aspergillosis
#55
JOURNAL ARTICLE
Daniel Z P Friedman, Elitza S Theel, Randall C Walker, Holenarasipur R Vikram, Raymund R Razonable, Paschalis Vergidis
We studied patients diagnosed with aspergillosis based on positive bronchoalveolar lavage (BAL) Aspergillus galactomannan (GM) who had follow-up BAL sampling within 180 days. GM trend and clinical outcome were concordant in only 60% (30/50). While useful for the initial diagnosis, BAL GM trending does not always correlate with treatment response.
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38555014/in-vivo-tracking-of-mesenchymal-stem-cell-dynamics-and-therapeutics-in-lps-induced-acute-lung-injury-models
#56
JOURNAL ARTICLE
Chen Wang, Kamal Hezam, Enze Fu, Kai Pan, Yue Liu, Zongjin Li
Mesenchymal stem cells (MSCs) have been widely used to treat various inflammatory and immune-related diseases in preclinical and clinical settings. Intravital microscopy (IVM) is considered the gold standard for investigating pathophysiological conditions in living animals. However, the potential for real-time monitoring of MSCs in the pulmonary microenvironment remains underexplored. In this study, we first constructed a lung window and captured changes in the lung at the cellular level under both inflammatory and noninflammatory conditions with a microscope...
March 28, 2024: Experimental Cell Research
https://read.qxmd.com/read/38551765/osteosarcoma-cells-exhibit-functional-interactions-with-stromal-cells-fostering-a-lung-microenvironment-conducive-to-the-establishment-of-metastatic-tumor-cells
#57
JOURNAL ARTICLE
Matías J P Valenzuela Alvarez, Luciana M Gutierrez, Juan M Bayo, María J Cantero, Mariana G Garcia, Marcela F Bolontrade
BACKGROUND: Osteosarcoma (OS) stands out as the most common bone tumor, with approximately 20% of the patients receiving a diagnosis of metastatic OS at their initial assessment. A significant challenge lies in the frequent existence of undetected metastases during the initial diagnosis. Mesenchymal stem cells (MSCs) possess unique abilities that facilitate tumor growth, and their interaction with OS cells is crucial for metastatic spread. METHODS AND RESULTS: We demonstrated that, in vitro, MSCs exhibited a heightened migration response toward the secretome of non-metastatic OS cells...
March 29, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38542450/age-dependent-inflammatory-microenvironment-mediates-alveolar-regeneration
#58
JOURNAL ARTICLE
Rui Quan, Chenhong Shi, Bing Fang, Yanan Sun, Taiqi Qu, Xifan Wang, Ran Wang, Yiran Zhang, Fazheng Ren, Yixuan Li
Lung aging triggers the onset of various chronic lung diseases, with alveolar repair being a key focus for alleviating pulmonary conditions. The regeneration of epithelial structures, particularly the differentiation from type II alveolar epithelial (AT2) cells to type I alveolar epithelial (AT1) cells, serves as a prominent indicator of alveolar repair. Nonetheless, the precise role of aging in impeding alveolar regeneration and its underlying mechanism remain to be fully elucidated. Our study employed histological methods to examine lung aging effects on structural integrity and pathology...
March 20, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38542260/upregulation-of-notch-signaling-and-cell-differentiation-inhibitory-transcription-factors-in-stable-chronic-obstructive-pulmonary-disease-patients
#59
JOURNAL ARTICLE
Antonino Di Stefano, Isabella Gnemmi, Umberto Rosani, Mauro Maniscalco, Silvestro Ennio D'Anna, Paola Brun, Vitina Carriero, Francesca Bertolini, Bruno Balbi, Fabio Luigi Massimo Ricciardolo
Notch signaling is involved in the prevention of cell differentiation and cell fate in various organs, including the lungs. We aimed to determine the transcriptomic and protein expression of Notch receptors, their ligands, and related transcription factors in stable COPD. The expression and localization of Notch receptors, their ligands, and related transcription factors were measured in bronchial biopsies of individuals with stable mild/moderate (MCOPD) (n = 18) or severe/very severe (SCOPD) (n = 16) COPD, control smokers (CSs) (n = 13), and control nonsmokers (CNSs) (n = 11), and in the lung parenchyma of those with MCOPD (n = 13), CSs (n = 10), and CNSs (n = 10) using immunohistochemistry, ELISA tests, and transcriptome analyses...
March 14, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38531171/efficacy-and-safety-of-mesenchymal-stem-cell-derived-microvesicles-in-mouse-inflammatory-arthritis
#60
JOURNAL ARTICLE
Shixiong Wei, Chenyang Lu, Sujia Li, Qiuping Zhang, Ruijuan Cheng, ShuYue Pan, QiuHong Wu, Xueting Zhao, Xinping Tian, Xiaofeng Zeng, Yi Liu
OBJECTIVE: To determine the effective and safe intravenous doses of mesenchymal stem cells (MSCs)-derived microvesicles (MVs) and to elucidate the possible causes of death in mice receiving high-dose MVs. METHODS: MVs were isolated from human MSCs by gradient centrifugation. Mice with collagen-induced arthritis were treated with different doses of intravenous MVs or MSCs. Arthritis severity, white blood cell count, and serum C-reactive protein levels were measured...
March 25, 2024: International Immunopharmacology
keyword
keyword
88417
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.